KRAS and neoplasm: The treatment of healthy and tumor cells with CAP under conditions of selective tumor-cell death stimulates largely similar types of transcriptional response: the up-regulation of the p53 pathway, KRAS signaling, the UV response, TNF-alpha signaling, and apoptosis-related processes.